There are organizations for the legalization of marijuana whose leaders would be satisfied with grass being legal and put on the open market, manufactured and sold by the companies now peddling nicotine. And then there’s Amorphia, Incorporated.
The latter sees the legalization of cannabis not as an end, but as a means to an end that is both revolutionary and capitalistic, but mostly ambitious.
In brief, Amorphia, Inc. hopes to take shape as a group of some 300 leaders in arts and letters, sciences and medicine who will push the fight for legalization of marijuana while cooperating on the fight against abuse of hard drugs. Too, Amorphia will be a profit corporation, with $5-per-share stockholders joining the 300 leaders as owners of the company, the company will then attempt to become the major marijuana manufacturer and distributor, administering a licensed-dealer system. Revenue from this new business——figured to be worth more than $2 billion a year——would serve as the economic foundation for development of what Amorphia calls “revolutionary life styles—support of over 100,000 people in prototype integrated communities” around the country.
At this point, Amorphia, Inc., a two-year-old idea of Blair Newman’s, is still mostly on paper. In terms of stage of growth, Newman hasn’t even scored his first seeds——the 300 persons for the “advisory committee.” Amorphia is incorporated in California, but, according to Newman, “There’ll be no real organization until the committee is formed. Then they’ll elect officers and decide on direction, structure and policies.”
Newman is hoping to get, onto the advisory group, prominent people who might be considered at home in the so-called psychedelic subculture while considered acceptable by the establishment—people like Alan Watts, Margaret Mead, Marshall McLuhan, Ted Roszak, Tom Wolfe, and Buckminster Fuller.
Their “job,” Newman said, would be to help sway the 85 per cent of the Gallup Poll public now said to be opposed to the legalization of marijuana. “That’s the only thing keeping grass from being legalized right now.” Newman used to live in Washington, D.C., where he owned “Washington’s only hip record store” and did head shows on WHFS-FM.
“The media, the advertising people, and the government are all pro-legalization,” he said, “but what we’ve got to do is prepare the public for acceptance of conclusive medical evidence that pot should be legal, that prohibition is unjustifiable. Even if the government had conclusive evidence now,” he said, “they wouldn’t release it now because of the Gallup Poll.”
The government, Newman hints, sees the benefits of legalizing grass through the eyes of the nation’s tobacco manufacturers, now shaking in their cancerous boots. Newman estimates there are 10 million people spending an average of $4 a week on grass. That’s at least $2 billion a year.” But he and Amorphia plan to out-joust the tobacco combines.
If the upstart company can indeed build up millions of dollars through stocks purchased by dopers – thereby gaining the support of the majority of potential pot “consumers” – Amorphia will market grass. (Newman has already taken out trademarks on the names “Panama Red” and “Acapulco Gold,” for papers now; for the real stuff later.)
Amorphia would then move on to its heaviest goal——the development of the prototype communities offering 20-hour-work weeks in everything, Newman says, “from gardening to systems analysis.” Specific plans for the creation of these systems would be developed by members of the advisory committee.
For now, Newman is busy answering questions, about his financial and power motives (He and his colleagues have agreed that he will have one vote on the 300-vote committee and .5 per cent of any eventual profits–—”about as much as I’d make in a successful rock band,” as Newman puts it).
Newman invites reactions to his plans. Amorphia, Inc. is reachable at 907 Fox Plaza building, San Francisco 94102.